Your browser doesn't support javascript.
loading
Inclusion of a core patient-reported outcomes battery in adolescent and young adult cancer clinical trials.
Roth, Michael E; Parsons, Susan K; Ganz, Patricia A; Wagner, Lynne I; Hinds, Pamela S; Alexander, Sarah; Bingen, Kristin; Bober, Sharon L; Brackett, Julienne; Cella, David; Henry, N Lynn; Indelicato, Daniel J; Johnson, Rebecca H; Miller, Tamara P; Rosenberg, Shoshana M; Schmitz, Kathryn H; Thanarajasingam, Gita; Reeve, Bryce B; Salsman, John M.
Affiliation
  • Roth ME; Division of Pediatrics and Patient Care, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Parsons SK; Department of Medicine, Division of Hematology/Oncology, Tufts Medical Center, and the Tufts University School of Medicine, Boston, MA, USA.
  • Ganz PA; Department of Medicine, Division of Hematology Oncology, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.
  • Wagner LI; Department of Social Sciences and Health Policy, Wake Forest School of Medicine and the Wake Forest Baptist Comprehensive Cancer Center, Winston Salem, NC, USA.
  • Hinds PS; Department of Nursing Science, Children's National Hospital, George Washington University School of Medicine, Washington, DC, USA.
  • Alexander S; Division of Haematology/Oncology, The Hospital for Sick Children, Department of Pediatrics, University of Toronto, Toronto, ON, Canada.
  • Bingen K; Division of Pediatric Psychology and Developmental Medicine, Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI, USA.
  • Bober SL; Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.
  • Brackett J; Pediatric Hematology-Oncology, Department of Pediatrics, Texas Children's Hospital, Houston, TX, USA.
  • Cella D; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA.
  • Henry NL; Division of Hematology/Oncology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.
  • Indelicato DJ; Department of Radiation Oncology, University of Florida, Jacksonville, FL, USA.
  • Johnson RH; Division of Pediatric Hematology/Oncology, Mary Bridge Children's Hospital, MultiCare Health System, Tacoma, WA, USA.
  • Miller TP; Aflac Cancer and Blood Disorders Center, Department of Pediatrics, Emory University, Atlanta, GA, USA.
  • Rosenberg SM; Department of Population Health Sciences, Weill Cornell Medicine, New York, NY, USA.
  • Schmitz KH; Public Health Sciences, Penn State College of Medicine, Hershey, PA, USA.
  • Thanarajasingam G; Division of Haematology, Mayo Clinic, Rochester, MN, USA.
  • Reeve BB; Department of Population Health Sciences, Department of Pediatrics, Duke University School of Medicine, Durham, NC, USA.
  • Salsman JM; Department of Social Sciences and Health Policy, Wake Forest School of Medicine and the Wake Forest Baptist Comprehensive Cancer Center, Winston Salem, NC, USA.
J Natl Cancer Inst ; 115(1): 21-28, 2023 01 10.
Article in En | MEDLINE | ID: mdl-36266760
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Clinical Trials as Topic / Patient Reported Outcome Measures / Neoplasms Type of study: Guideline / Prognostic_studies Aspects: Patient_preference Limits: Adolescent / Adult / Humans Language: En Journal: J Natl Cancer Inst Year: 2023 Document type: Article Affiliation country: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Clinical Trials as Topic / Patient Reported Outcome Measures / Neoplasms Type of study: Guideline / Prognostic_studies Aspects: Patient_preference Limits: Adolescent / Adult / Humans Language: En Journal: J Natl Cancer Inst Year: 2023 Document type: Article Affiliation country: Estados Unidos